Dr. Gandara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Sacramento, CA 95817Phone+1 916-734-3771
Education & Training
University of Texas Medical Branch School of MedicineClass of 1973
Certifications & Licensure
HI State Medical License 2022 - 2026
CA State Medical License 1978 - 2025
WA State Medical License 1975 - 2003
TX State Medical License 1973 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsLung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400).David Kozono, Xing Hua, Michael C Wu, Khaled A Tolba, Saiama N Waqar
Journal of Thoracic Oncology. 2024-12-01 - S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma.Anne S Tsao, Ming-Hui Hsieh, Marianna Koczywas, Janet Tu, Jonathan Riess
JTO Clinical and Research Reports. 2024-12-01 - KRAS G12C Inhibitors: New Drugs, A New Hope.Surbhi Singhal, Shiruyeh Schokrpur, David Gandara, Jonathan W Riess
Journal of Thoracic Oncology. 2024-12-01
Press Mentions
New Test Influences First-Line Therapy Decisions for Metastatic NSCLC PatientsJuly 29th, 2024- Clinical Lung Cancer Publishes Study: 93% of Oncologists Adjust Treatment Recommendations with OncoHost's PROphetNSCLC™ TestJuly 29th, 2024
- GO2 for Lung Cancer to Honor David Carbone, MD, PhD with the 2023 Bonnie J. Addario Lectureship AwardJuly 30th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
